tiprankstipranks
Top Stocks
U.S. Stock Market OverviewTop Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
Top ETFs by AUMSPY ETFQQQ ETF
Stock Comparison
Energy StocksOil StocksBest Value StocksAirline StocksElectric Vehicle StocksMATANA Stocks
New
Bank StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
Global Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsPre-Market BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsTools for Trading PlatformsData for Hedge FundsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Top ETFs by AUM
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
U.S. Markets
Market Movers
Expert Center
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
Top ETFs by AUM
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Energy Stocks
EV Stocks
Crypto News
Dividend Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Pre-Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

VRDN Stock Latest News

Viridian Therapeutics removed from tactical outperform list at Evercore ISI
The FlyViridian Therapeutics removed from tactical outperform list at Evercore ISI
15d ago
VRDN
Viridian Therapeutics price target raised to $46 from $40 at B. Riley
The FlyViridian Therapeutics price target raised to $46 from $40 at B. Riley
17d ago
VRDN
Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating Low Dose VRDN-001 in Patients with Thyroid Eye Disease (TED)
Press ReleasesViridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating Low Dose VRDN-001 in Patients with Thyroid Eye Disease (TED)
19d ago
VRDN
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesViridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22d ago
VRDN
‘The Likelihood of Recession in the Next 6 Months Is Low’: Credit Suisse Suggests 2 Stocks to Buy
Stock Analysis & Ideas‘The Likelihood of Recession in the Next 6 Months Is Low’: Credit Suisse Suggests 2 Stocks to Buy
25d ago
CNHI
VRDN
Viridian Therapeutics Announces First Patient Enrolled in the ‘THRIVE’ Phase 3 Trial in Patients With Thyroid Eye Disease
Press ReleasesViridian Therapeutics Announces First Patient Enrolled in the ‘THRIVE’ Phase 3 Trial in Patients With Thyroid Eye Disease
1M ago
VRDN
Viridian Therapeutics announces first patient enrolled in THRIVE Phase 3 trial
The FlyViridian Therapeutics announces first patient enrolled in THRIVE Phase 3 trial
1M ago
VRDN
Viridian Therapeutics initiated with a Buy at Needham
The FlyViridian Therapeutics initiated with a Buy at Needham
1M ago
HZNP
VRDN
Viridian Therapeutics initiated with an Outperform at Credit Suisse
The FlyViridian Therapeutics initiated with an Outperform at Credit Suisse
1M ago
VRDN
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesViridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2M ago
VRDN
Looking for Red-Hot Takeover Candidates? Here Are 2 Stocks on Analysts’ Radar
Stock Analysis & IdeasLooking for Red-Hot Takeover Candidates? Here Are 2 Stocks on Analysts’ Radar
2M ago
DNN
VRDN
Viridian Therapeutics initiated with a Buy at H.C. Wainwright
The FlyViridian Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
VRDN
Viridian Therapeutics reports Q3 EPS (86c), consensus (95c)
The FlyViridian Therapeutics reports Q3 EPS (86c), consensus (95c)
2M ago
VRDN
Viridian Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Updates
Press ReleasesViridian Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Updates
2M ago
VRDN
Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Thyroid Eye Disease (TED)
Press ReleasesViridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Thyroid Eye Disease (TED)
2M ago
VRDN
Viridian Therapeutics to Participate in Guggenheim 4th Annual Neuro/Immunology Conference on November 15th
Press ReleasesViridian Therapeutics to Participate in Guggenheim 4th Annual Neuro/Immunology Conference on November 15th
3M ago
VRDN
Viridian Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 14, 2022
Press ReleasesViridian Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 14, 2022
3M ago
VRDN
Viridian Presents Positive Clinical Data from Ongoing VRDN-001 Phase 1/2 Trial in Active Thyroid Eye Disease (TED) Patients During Late-Breaking Presentations at the American Thyroid Association (ATA) 91st Annual Meeting
Press ReleasesViridian Presents Positive Clinical Data from Ongoing VRDN-001 Phase 1/2 Trial in Active Thyroid Eye Disease (TED) Patients During Late-Breaking Presentations at the American Thyroid Association (ATA) 91st Annual Meeting
3M ago
VRDN
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesViridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5M ago
VRDN
Viridian Therapeutics Announces Exercise in Full and Closing of Underwriters’ Option to Purchase Additional Shares in Public Offering
Press ReleasesViridian Therapeutics Announces Exercise in Full and Closing of Underwriters’ Option to Purchase Additional Shares in Public Offering
5M ago
VRDN
Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock
Press ReleasesViridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock
5M ago
VRDN
Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
Press ReleasesViridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
6M ago
VRDN
Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates
Press ReleasesViridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates
6M ago
VRDN
Viridian Announces Positive Initial Clinical Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Thyroid Eye Disease (TED)
Press ReleasesViridian Announces Positive Initial Clinical Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Thyroid Eye Disease (TED)
6M ago
VRDN
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesViridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6M ago
VRDN
Oppenheimer Bets on These 2 Stocks; Sees Over 40% Upside Potential
Stock Analysis & IdeasOppenheimer Bets on These 2 Stocks; Sees Over 40% Upside Potential
11M ago
SRRA
VRDN